Results 51 to 60 of about 44,319 (309)
Infectious diseases and autoimmunity [PDF]
, 2011 Introduction: Autoimmunity occurs when the immune system recognizes and attacks host tissue. In addition to genetic factors, environmental triggers (in particular viruses, bacteria and other infectious pathogens) are thought to play a major role in the ...
Deidda, Silvia +3 more
core +1 more source
Low‐field MRI: Clinical promise and challenges
Journal of Magnetic Resonance Imaging, Volume 57, Issue 1, Page 25-44, January 2023., 2023 Modern MRI scanners have trended toward higher field strengths to maximize signal and resolution while minimizing scan time. However, high‐field devices remain expensive to install and operate, making them scarce outside of high‐income countries and major population centers.
Thomas Campbell Arnold +3 more
wiley +1 more source
Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update [PDF]
, 2019 Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system (CNS) with brain neurodegeneration. MS patients present heterogeneous clinical manifestations in which both genetic and environmental factors are involved ...
Bruna Lo Sasso +4 more
core +1 more source
Long‐Term COVID‐19 Smell and Taste Disorders Differ Significantly from Other Post‐Infectious Cases
The Laryngoscope, Volume 133, Issue 1, Page 169-174, January 2023., 2023 Introduction COVID‐19 is causing a wide range of clinical manifestations. Severe complications and long‐lasting sequelae have been identified. Thus, olfactory disorders are reported in up to 86% of cases in mild and moderate COVID‐19 infections. We present the first study comparing simple and complex post‐COVID‐19 cases with matched non‐COVID‐19 post ...
Dovile Stankevice +3 more
wiley +1 more source
Frontiers in Genetics, 2019 Exosomes can pass through the blood-brain barrier and are present in the cerebrospinal fluid (CSF). The components in exosomes, such as DNA, RNA, protein, and lipids, change greatly and are closely related to disease progression.
Jinting He +6 more
doaj +1 more source
Learning Myelin Content in Multiple Sclerosis from Multimodal MRI through Adversarial Training [PDF]
, 2018 Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). A reliable measure of the tissue myelin content is therefore essential for the understanding of the physiopathology of MS, tracking progression and assessing treatment efficacy.
arxiv +1 more source
Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis [PDF]
, 2012 Schwann cell (SC) transplantation is currently being discussed as a strategy that may promote functional recovery in patients with multiple sclerosis (MS) and other inflammatory demyelinating diseases of the central nervous system (CNS).
Bachelin, Corinne +9 more
core +3 more sources
Peripheral Demyelinating Diseases: From Biology to Translational Medicine
Frontiers in Neurology, 2019 Demyelinating diseases represent a spectrum of disorders that impose significant burden on global economy and society. Generally, the prognosis of these diseases is poor and there is no available cure.
Khidhir Kamil +4 more
doaj +1 more source
Differential diagnosis of demyelinating diseases: what's new?
Arquivos de Neuro-Psiquiatria, 2022 Background: Acquired demyelinating disorders lead to overlapping visual, pyramidal, sensory, autonomic, and cerebellar deficits and may lead to severe disability.
Ana Beatriz Ayroza Galvão Ribeiro Gomes +1 more
doaj +1 more source
Anaesthesia and demyelinating disease [PDF]
Anaesthesia, 1980 SummaryThe demyelinating diseases are classified and the current concepts of the aetiology and pathophysiology of the most common of these diseases, multiple sclerosis, are described. The effects of the impaired function, local responses and known complications of the disease on the choice of anaesthetic, drugs and techniques are discussed.
T. E. J. Healy, Ronald M. Jones
openaire +3 more sources